vandetanib 100 MG Oral Tablet [Caprelsa]

RxCUI: 1114074
RxNorm name: vandetanib 100 MG Oral Tablet [Caprelsa]
Display name: vandetanib 100 MG Oral Tablet [Caprelsa]
Full name: vandetanib 100 MG Oral Tablet [Caprelsa]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CAPRELSA	VANDETANIB	Genzyme Corporation	e5721cb8-4185-47b9-bbb3-1c587e558a03	2026-04-23	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1114074

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e5721cb8-4185-47b9-bbb3-1c587e558a03	Caprelsa 100 MG Oral Tablet [PSN] · vandetanib 100 MG Oral Tablet [Caprelsa] [SBD] · Caprelsa 100 MG Oral Tablet [SY]	3	14	These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA ® (vandetanib) tablets, for oral use Initial U.S. Approval: 2011	20260423